Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Allopregnanolone increases KCC2 expression in baby male rats' brains, while finasteride doesn't affect it.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

PEGylated flavonoid Aspasomes improve brain protection and memory in stress-related disorders.

The lotion helps manage mild to moderate hair loss.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

The tool iCOUNT helps understand how stem cells divide and affect tissue development and repair.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

Skin patting and iontophoresis with dutasteride gel improved hair growth in people with androgenetic alopecia.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Prednisolone can quickly regrow hair in alopecia universalis, but hair falls out after stopping it.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Progesterone protects brain cells, but Provera does not.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Ishige sinicola extract helps bone-building cells grow and mature, which could aid in treating osteoporosis.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

The treatment slightly increased hair growth and was safe for most women.